Detalhe da pesquisa
1.
Onset of Alzheimer disease in apolipoprotein É4 carriers is earlier in butyrylcholinesterase K variant carriers.
BMC Neurol
; 24(1): 116, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594621
2.
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
Circ Res
; 120(2): 324-331, 2017 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821724
3.
ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.
JAMA Ophthalmol
; 142(4): 301-308, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421662
4.
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
Am Heart J
; 165(6): 854-861.e2, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23708155
5.
Pelizaeus-Merzbacher Disease: A Caregiver Assessment of Disease Impact.
J Child Neurol
; 38(1-2): 78-84, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744386
6.
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial.
JAMA Neurol
; 80(12): 1344-1352, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902726
7.
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Nat Med
; 29(6): 1437-1447, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095250
8.
Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.
Am Heart J
; 164(5): 689-697.e3, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23137499
9.
Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Nat Med
; 30(1): 304, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845513
10.
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
JACC Cardiovasc Interv
; 9(15): 1576-85, 2016 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27491607
11.
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
Cell Transplant
; 25(9): 1701-1711, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151378
12.
A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
Circ Cardiovasc Interv
; 5(6): 821-30, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23192920
13.
Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus.
Mol Brain
; 4: 32, 2011 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21827709
14.
The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.
J Biol Chem
; 284(19): 12862-73, 2009 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19240037
15.
Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1.
J Biol Chem
; 283(29): 20600-11, 2008 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18474593
16.
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia.
Proc Natl Acad Sci U S A
; 100(22): 13019-24, 2003 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-14559973
17.
Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.
Exp Neurol
; 188(1): 94-103, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15191806